prognostic [inpr]
Nodal [spco]
Status [qlco]
Asymptomatic [fndg]
Insufficiency [ftcn]
Patients [podg]
HER-2 [aapp, enzy, rcpt]
Breast Cancer [neop]
treated [topp]
Chemotherapy [topp]
radiotherapy [inpr]
trastuzumab [aapp, imft, phsu]
Adjuvant [chvf]
setting [ftcn]
Present [qnco]
Study [mnob]
Metastasis [neop]
free [ftcn]
Survival [acty]
Patients [podg]
human epidermal growth factor receptor 2 [aapp, enzy, rcpt]
HER-2 [aapp, enzy, rcpt]
Breast Cancer [neop]
treated [topp]
Chemotherapy [topp]
radiotherapy [inpr]
trastuzumab [aapp, imft, phsu]
Adjuvant [chvf]
setting [ftcn]
Sub- [spco]
Cardiac [bpoc]
side effects [ftcn]
Parameters [fndg]
tested [inpr]
Evaluated [ftcn]
Before [tmco]
trastuzumab [aapp, imft, phsu]
therapy [ftcn]
Select [acty]
Parameters [fndg]
Series [qnco]
Left ventricular ejection fraction [clna]
Decreased [qnco]
trastuzumab [aapp, imft, phsu]
treatment [ftcn]
therapy [ftcn]
P NOS [aapp, imft]
Revealed [qlco]
Decrease [qlco]
Patients [podg]
Received [qlco]
radiotherapy [inpr]
VALVE [medd]
Insufficiency [ftcn]
trastuzumab [aapp, imft, phsu]
therapy [ftcn]
P NOS [aapp, imft]
Revealed [qlco]
pN2a Stage [fndg]
VALVE [medd]
Regurgitation [fndg]
trastuzumab [aapp, imft, phsu]
therapy [ftcn]
lack [qlco]
VALVE [medd]
Insufficiency [ftcn]
Insufficiency [ftcn]
trastuzumab [aapp, imft, phsu]
therapy [ftcn]
Independent [idcn]
Negative [qlco]
VALVE [medd]
Insufficiency [ftcn]
Diagnosed [fndg]
trastuzumab [aapp, imft, phsu]
Application [hlca]
Unrelated [fndg]
indicator [irda]
Decreased Sensitivity [fndg]
